Addiction Science & Clinical Practice

Papers
(The median citation count of Addiction Science & Clinical Practice is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou67
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series54
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals48
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series35
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis32
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use31
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with 28
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)24
“Cigarettes led me back to smoking tik”: lived experience perspectives on tobacco use during substance use treatment and recovery in South Africa23
Effects of different exercise types on craving in substance use disorder patients with drug dependence -network meta-analysis and dose-response relationships based on frequentist and Bayesian models22
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda20
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study19
Implementation process evaluation and preliminary effect analysis of an outpatient multidisciplinary follow-up program for adolescents with acute alcohol intoxication in Belgium: the SPIRIT pilot stud19
Virtual reality interventions in the assessment and treatment of alcohol use disorder - a systematic scoping review on methodology19
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study17
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access17
Implementation outcomes and strategies of a peer recovery coach program: findings from a qualitative assessment in the U.S. South, 2024–202516
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process16
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial16
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use15
Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities15
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study15
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial14
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder14
Trial experiences with dyadic breathalyzer technology for alcohol monitoring and feedback among couples living with HIV in South Africa14
Patient evaluation of a smartphone application for telehealth care of opioid use disorder14
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population14
Study protocol for a randomized trial examining a peer grief support approach for people grieving drug overdose deaths14
Adapting the Grog survey app for alcohol screening and feedback in aboriginal and Torres Strait Islander health services: a mixed methods study protocol13
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder13
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State13
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 202413
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study12
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda12
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods12
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis12
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps12
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham12
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits11
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation11
Implementation of low-dose buprenorphine induction at a syringe services program11
Proceedings of the 18th Annual Conference of INEBRIA11
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical 11
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program10
Iatrogenic physiologic opioid dependence masquerading as recurrent acute pancreatitis flares: case series10
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 202310
Substance use disorder bridge clinics: models, evidence, and future directions10
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics10
“It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management10
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis10
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches10
The development and initial validation of the Russian version of the BASIS-249
A systematic review of substance use screening in outpatient behavioral health settings9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants9
Patient experiences of buprenorphine dispensing from a mobile medical unit9
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions9
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders9
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder9
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis9
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study9
A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail9
24-48 h initiation by transdermal buprenorphine for the treatment of opioid use disorder in the inpatient setting: a retrospective chart review9
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries9
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d8
Rethinking trazodone for insomnia in alcohol use disorder8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods8
Comparison of heroin and fentanyl use in US nationally representative surveys8
A mixed methods analysis of clinics’ perspectives on community factors influencing access to medications for opioid use disorder8
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey8
Factors associated with alcohol screening and brief interventions: a cross-sectional study of cardiology clinicians in Sweden8
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder8
Understanding overdose risk and response in permanent supportive housing: results of focus groups with tenants, staff, and leaders7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care7
Expedited referrals from community health center to opioid treatment program: innovative approaches to improving access to methadone treatment for patients who use opioids and experience homelessness7
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky7
Using a quality improvement framework to evaluate the feasibility of implementing a patient-reported outcome measure for recovery in an office-based treatment setting for opioid use disorder7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial7
Rural providers’ attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder7
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper6
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors6
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec6
Proceedings of the 17th Annual International INEBRIA Conference6
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services6
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single 6
Attitudes and training related to substance use in pediatric emergency departments6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders5
A lifeline on wheels: perspectives of stakeholders on the implementation and impact of a mobile medications for opioid use disorder unit5
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities5
Impact of social determinants on opioid use disorder treatment engagement after release from jail: a case note content analysis5
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review5
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study5
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare5
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs5
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education5
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography5
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany5
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial5
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa5
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population5
Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care4
Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcoh4
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway4
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population4
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories4
Tracking functional recovery in a community-based substance use disorder program: a five-year descriptive evaluation using the brief addiction monitor4
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital4
The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysis4
Alcohol reduction strategies among persons with HIV: past attempts, self-reported effectiveness, and future strategies of interest4
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings4
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol4
Ketamine-assisted buprenorphine initiation: a pilot case series4
Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers4
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study4
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis4
Expanding access to medications for opioid use disorder through locally-initiated implementation4
Grayken Lessons: a patient who developed opioid use disorder after traumatic brain injury4
Prevalence and predictors of suicidality among adults initiating office-based buprenorphine4
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services4
Perceptions of family physicians in Istanbul about e-cigarettes as smoking cessation aids: a qualitative study4
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial4
Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial4
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study4
Organization of primary care and early MOUD discontinuation3
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis3
Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial3
GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study3
Connect To Care (C2C): protocol for two-site randomized controlled pilot trial to improve outcomes for patients with hazardous drinking and PTSD and/or depression symptoms3
Preoperative evaluation of alcohol consumption in older patients3
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial3
Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports3
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary3
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study3
Usability and cultural adaptation of a text message-based tobacco cessation intervention for people living with HIV in Uganda and Zambia3
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder3
App-based skills training to reduce problem drinking among adult internet help-seekers: a double-blinded randomized controlled trial3
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy3
Treatment of alcohol use disorder via magnetic resonance-guided focused ultrasound ablation surgery3
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County3
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder3
Reasons for not seeking alcohol treatment among a sample of Florida adults with HIV who perceived the need for treatment3
Barriers and facilitators of opioid treatment among Indigenous Syringe Services Program clients3
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model3
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?3
Mobile addiction treatment units: a narrative review3
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems3
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study3
Correction: Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder2
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report2
Perspectives of people who use drugs on implementing overdose response technologies in acute care settings: a qualitative study2
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations2
A case of severe opioid and methamphetamine use disorder in a 14 year old2
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England2
The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-di2
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work2
The tracking and reducing alcohol consumption (TRAC) intervention for veterans living with HIV/AIDS: results from a pilot randomized waitlist-controlled trial2
How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky2
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder2
Correction: Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial2
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study2
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study2
Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016–20182
“Ignite & engage:” A mixed methods evaluation of a peer-led, school-based substance use prevention program2
Attachment styles and sense of coherence as indicators of treatment adherence and completion among individuals with substance use disorder2
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites2
Exploring perceptions of genetic risk and the transmission of substance use disorders2
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment2
Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial2
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals2
“There’s a lot of people who love them, so why call ‘em junkies?”: clinician and patient perspectives about words used to describe people who use drugs2
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial2
Confidence in providing methadone maintenance treatment of primary care providers in Vietnam2
Inpatient addiction care is associated with increased vaccinations, medication for opioid use disorder and naloxone prescribing among patients with infective endocarditis in a rural state2
Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort Study2
Addressing substance use and mental illness among Quinault Indian Nation adolescents and young adults: community perspectives on community and cultural connection2
Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder2
Observational trial of the preventive impact of a social risk factor focused program for co-occurring opioid and methamphetamine use disorders and suicide risk in parents: study protocol2
Does perceived stigma impact opioid use disorder treatment uptake? A cross-sectional secondary analysis of buprenorphine engagement among syringe service program participants2
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report2
Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project2
Repetitive transcranial magnetic stimulation for stimulant use disorders (STIMULUS): protocol for a multi-site, double-blind, randomized controlled trial2
A novel online vaping intervention and smoking prevention program for young adults who vape: protocol for a randomized controlled trial2
A qualitative interview study of patient experiences of receiving motivational enhancement therapy in a Swedish addiction specialist treatment setting2
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder2
Acceptability of “DIDE”, a mobile application designed at facilitating care adherence of patients with substance use disorder2
“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke2
Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder2
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey2
Survey of Massachusetts peer recovery coaches’ attitudes toward the use of psychedelics to treat substance use disorders2
Augmenting project ECHO for opioid use disorder with data-informed quality improvement2
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review2
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study2
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities2
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes2
Inpatient detoxification for alcohol and other drug use: qualitative study of patients’ accounts of their relationships with staff2
Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users2
The identification and treatment of alcohol problems in primary care (iTAPP) study: protocol for a stepped wedge cluster randomized control trial testing the 15-method in a primary care setting2
Assessing craving in cocaine and cocaine base paste users: validation of the Cocaine Craving Questionnaire-Brief in a Chilean sample2
0.1706211566925